ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 647614 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 647614; 2) Community: the network communities that were significantly associated with the response to NSC 647614; 3) Molecule: the relationships between components within communities and NSC 647614; 4) MDR: the compounds that were significantly associated with the NSC 647614.

NSC Compound Enrichment Correlation
NSC 646278 Pyrido[3',4':4,5]thieno[2,3-g]isoquinoline, 6-methyl- 0.0177048892222172 0.42757452
NSC 664529 Null 0.0177048892222174 0.27145571
NSC 683920 Null 0.0177048892222174 0.2258505
NSC 695937 9-Acridinone, 1-[[[[(9-methoxy-5,11-dimethyl- 6H-pyrido[4,3-b]carbazol-1-yl)amino]-3-propyl(methyl) amino]-3-propyl]amino]-4-nitro-, dimethane sulfonate salt 0.0177048892222174 0.1921764
NSC 719480 Null 0.0177048892222174 -0.10637095
NSC 758662 Lovastatin [USAN] 0.0177048892222174 -0.15623662
NSC 668259 Null 0.0193573267900279 0.27342966
NSC 668264 Null 0.0193573267900279 0.31227027
NSC 670688 Null 0.0193573267900279 0.4142268
NSC 688074 16,24-Cyclo-13,14-secoergost-2-ene-18,26-dioic acid, 5-chloro-14,17:14,27-diepoxy-6,13,20,22-tetrahydroxy-1,15-dioxo-, .gamma.-lactone .delta.-lactone 0.0193573267900279 0.2984119
Total:76  Current:31    [First] [Prev] [Next] [Last]